The pace of change to value-based payments has been happening quickly, but the real test is whether or not these payments produce higher quality and more affordable care, said Suzanne Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform.
The pace of change to value-based payments has been happening quickly, but the real test is whether or not these payments produce higher quality and more affordable care, said Suzanne Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform.
Transcript
Has the move to value-based payments been happening as quickly as you expected?
When we got started in 2010, there was so little value-based payment; It was maybe between 1% and 3% of payments, and in the last 7-and-a-half, 8 years, we’re at 50% now. So, I think that’s a pretty remarkable and fast change to how were paying healthcare providers. The big question is, how well are these payments working to produce the higher quality and more affordable care that we hoped they would?
What have been the outcomes seen so far in the move to value-based payments?
As a whole, I would say the outcomes of these value-based payment movement and the growth of payment reform are mixed. So far, we’ve seen some really great examples of improvements in certain quality measures and even more efficient use of resources. But, we’ve also seen examples of where there were really disappointing results, and we can’t even specify the positive or negative results by payment method. Even within a program and bundled payment, you might see some quality measures getting better, and some not. In an ACO environment supported by shared savings, you might see that length of stay in the hospital was reduced, but there was no impact on adherence to guideline for diabetes care. So far, were seeing real mixed results, even by payment methods.
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More